What is the male-to-female ratio of urinary tract infections (UTIs) in India?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Male-to-Female Ratio of UTI in India

In India, females have approximately 2-3 times higher prevalence of UTI compared to males, with the female-to-male ratio ranging from approximately 2:1 to 3:1 in community settings.

Gender Distribution in Indian Studies

The available Indian data consistently demonstrates a clear female predominance in UTI prevalence:

  • In Meerut City, the UTI prevalence was 73.57% in females versus 35.14% in males, representing approximately a 2.1:1 female-to-male ratio 1.

  • In Assam, North-East India, among culture-positive UTI cases, 73.07% were females and 26.92% were males, yielding approximately a 2.7:1 female-to-male ratio 2.

  • In the eastern part of Northern India, females had a 60.7% prevalence compared to 39.3% in males, representing approximately a 1.5:1 ratio 3.

Age-Related Patterns

The gender distribution varies significantly with age:

  • Young to middle-aged women (18-50 years, particularly 26-36 years) show the highest UTI prevalence 1, 3.

  • Elderly males (≥48 years and 51-80 years) demonstrate increased susceptibility, narrowing the gender gap in older age groups 1, 3.

  • The male-to-female prevalence difference becomes less pronounced in elderly populations 4.

Clinical Context

This female predominance in India mirrors global patterns:

  • Women are approximately 30 times more likely than men under 50 years to develop UTI 5.

  • The higher female prevalence relates to anatomical factors, sexual activity, and hormonal influences 4.

  • Escherichia coli remains the predominant uropathogen (42.58-55.0%) in Indian community-acquired UTIs 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.